Iodide

Iodide

SCHEMBL4080888

CCOc1cc(N)ccc1C1CCN(C)CC1.I

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 2/20 0.48
HTR1B P28222 2/20 0.48
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
KCNH2 Q12809 2/20 0.41
QDPR P09417 1/20 0.39
SSTR4 P31391 2/20 0.39
DRD2 P14416 1/20 0.38
SSTR1 P30872 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TRPC6 Q9Y210 1/20 0.37
HTR1F P30939 1/20 0.36
PROKR1 Q8TCW9 1/20 0.36
ADRA2C P18825 1/20 0.36
CCR5 P51681 1/20 0.35
APP P05067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962643 0.99 HTR1D (0.49) HTR1DHTR1BGAAMAPTKDM4E
SCHEMBL4562943 0.99 HTR1D (0.49) HTR1DHTR1BGAAMAPTKDM4E
SCHEMBL25565747 0.85 CHRM4 (0.43) HTR1DHTR1BGAAMAPTKDM4E
SCHEMBL23978364 0.84 ADRA2A (0.47) HTR1DHTR1BKCNH2QDPRSSTR4
SCHEMBL282999 0.82 QDPR (0.52) HTR1DHTR1BGAAMAPTQDPR
SCHEMBL30496473 0.82 QDPR (0.52) HTR1DHTR1BGAAMAPTQDPR
SCHEMBL30020108 0.79 HTR1D (0.49) HTR1DHTR1BMAPTKDM4EKCNH2
SCHEMBL20899575 0.77 MAPT (0.47) GAAMAPTKDM4ETP53TRPC6
SCHEMBL26040667 0.77 HTR1D (0.52) HTR1DHTR1BMAPTKDM4EQDPR
SCHEMBL10036163 0.76 HTR1D (0.49) HTR1DHTR1BQDPRDRD2HTR1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270450-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-10-29 US disclosed
EP-2084134-A1 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2009-08-05 EP disclosed
WO-2008056148-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270450-A1 CHEMICAL COMPOUNDS CSF1R, CSF3R, FLT3 HTR1D 3252/4885HTR1B 3668/4885GAA 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.